Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 544 of 6351
-
Heated chemo during surgery may stop stomach Cancer's return
Prevention By invitation onlyThis phase II trial tests how well concentrating heated (hyperthermic) chemotherapy in the area that contains the abdominal organs (intraperitoneal \[IP\]) at the time of surgery works in treating patients with gastric or gastroesophageal junction adenocarcinoma at high risk of t…
Phase 2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New hope for Tough-to-Treat gut cancer: experimental drug takes on standard therapy
Disease control Recruiting nowThe purpose of this study is to find out if a new drug, called IDRX-42 (also known as GSK6042981), is effective in treating adults with a type of cancer called Gastrointestinal Stromal Tumors (GIST) when compared to another drug named sunitinib. The study will see if IDRX-42 work…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New study tests ribociclib combo to stop breast cancer return
Disease control Recruiting nowThis prospective, observational, multicenter study aims at evaluating the efficacy of adjuvant ribociclib in combination with hormone therapy (aromatase inhibitor ± GnRH aginost) in various subgroups of patients with HR+HER2- stage II-III breast cancer in real clinical practice i…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Immunotherapy combo aims to stop cervical cancer in its tracks
Disease control Recruiting nowThis study is a randomized, controlled, open-label, phase II clinical trial designed to enroll patients with previously untreated locally advanced cervical cancer. The study aims to evaluate the efficacy and safety of adding chemotherapy to serplulimab combined with concurrent ch…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Flu vaccine may shield heart attack survivors from future cardiac events
Prevention Recruiting nowThe goal of this clinical trial is to learn if influenza vaccination can prevent adverse cardiac events in Chinese acute coronary syndrome patients. The main questions it aims to answer are: * Whether influenza vaccination can decrease events of cardiovascular death, MI, or stro…
Sponsor: Tongji Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to tackle resistant lymphomas
Disease control Recruiting nowThe purpose of this study is to understand and determine if ruxolitinib added to pembrolizumab is safe and effective for the treatment of relapsed or refractory Hodgkin and non-Hodgkin lymphomas.
Phase 2 • Sponsor: Seda S. Tolu • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill could replace shots for Kidney-Related anemia
Disease control Recruiting nowThis is a Phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in non-dialysis-dependent (NDD)-CKD patients compared with the active control, ESA treatment
Phase 3 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a cholesterol shot boost stroke recovery?
Disease control Recruiting nowThis prospective multicenter cohort study aims to evaluate the effectiveness and safety of early PCSK9 inhibitor therapy in patients with large-artery atherosclerotic ischemic stroke. The study will compare early neurological improvement, lipid-lowering effect, 90-day functional …
Sponsor: First Affiliated Hospital of Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot could clear teen psoriasis – trial underway
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of IBI112 in the treatment of adolescent participants with moderate to severe plaque-type psoriasis.
Phase 3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can laser guidance make lung biopsies safer and more accurate?
Diagnosis CompletedThis prospective, single-center, randomized controlled trial compares pCLE-guided TBLC with conventional TBLC in patients with suspected interstitial lung disease. The study evaluates whether pCLE guidance improves diagnostic performance and procedural safety, with outcomes inclu…
Sponsor: China-Japan Friendship Hospital • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Can a diabetes pill shield hearts and kidneys after ICU?
Disease control Recruiting nowSeveral millions of patients are admitted to ICUs in Europe or USA each year. We and others, have shown that patients discharged from intensive care units (ICU) have a high incidence of cardiovascular and/or renal events and high mortality rate (22%) during the year following ICU…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for Hard-to-Treat ovarian cancer: drug combo trial launches
Disease control Recruiting nowThis study is an open-label, multicenter Phase Ib/II clinical trial of LBL-024 in combination with other drugs for the treatment of patients with platinum-resistant ovarian cancer (OC), aiming to evaluate the efficacy and safety of LBL-024 in combination with other drugs in the t…
Phase 1/2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for kids with transplant complication: belumosudil trial launches
Disease control Recruiting nowThis is an open-label, single group, Phase 1/2, 1-arm study for treatment of children aged 1 to \<18 years with active moderate-to-severe cGVHD that is refractory to or recurred after at least 2 prior lines of systemic therapy for cGVHD. The purpose of Phase 1 is to determine th…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug combo aims to wipe out hidden myeloma cells
Disease control Recruiting nowThe purpose of this study is to determine whether giving linvoseltamab with lenalidomide during maintenance treatment to participants with multiple myeloma will: 1. Get rid of any residual multiple myeloma cells in participants' bodies which is known as minimal residual disease …
Phase 2 • Sponsor: Dickran Kazandjian, MD • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New scan could spot pancreatic cancer relapse months earlier
Diagnosis Recruiting nowAssessment of the relevance of a new medical imaging test, FAPI PET, which could detect progression or relapse earlier than other tests currently available. Ultimately, it could enable early forms of pancreatic cancer to be detected and used for screening. In addition to the usu…
Phase 2 • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
New liquid drug offers hope for kids with severe eczema
Disease control Recruiting nowThis 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in children 2 years of age or older with moderate-to-severe atopic dermatitis. The study will enroll two groups: participants who have compl…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can the shingles vaccine protect those with autoimmune conditions?
Prevention Recruiting nowThis interventional phase IV clinical trial will evaluate the efficacy, immunogenicity and safety of the adjuvanted recombinant herpes zoster vaccine (RZV) in adults with autoimmune rheumatic diseases (ARDs) receiving immunomodulatory monotherapy. Humoral immune response will be …
Phase 4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
One-Stop stroke care could save minutes and lives
Disease control Recruiting nowStroke, especially acute ischemic stroke (AIS) caused by a blocked blood vessel in the brain, is a leading cause of death and long-term disability. When the blockage is in a large blood vessel, a procedure called endovascular therapy (EVT)-where the clot is removed using a cathet…
Sponsor: Prof. Dr. Jan Liman • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for Hard-to-Treat lung cancer: targeted drug combo shows promise
Disease control Recruiting nowTo assess safety and efficacy of amivantamab plus monochemotherapy in terms of ORR, PFS and OS in subjects with EGFR exon20 insertion mutations metastatic non-small cell lung cancer unfit for platinum-based chemotherapy.
Phase 2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug combo aims to fight deadly gallbladder cancer
Disease control Recruiting nowThis is a randomized, open-label, phase II study evaluating first-line treatment for advanced gallbladder cancer. It aims to assess the efficacy, safety, pharmacokinetics, and immunogenicity of the ZG005 in Combination with gemcitabine and cisplatin as first-line therapy in Parti…
Phase 2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC